Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 8Stomach Neoplasms 5Carcinoma, Non-Small-Cell Lung 4Lung Neoplasms 3Pathologic Complete Response 2Triple Negative Breast Neoplasms 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Non-squamous Non-small Cell Lung Cancer 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1HER2 Positive Breast Cancer 1Esophageal Squamous Cell Carcinoma 1EGFR Positive Non-small Cell Lung Cancer 1Breast Diseases 1Advanced Non-small-cell Lung Cancer 1Advanced Gastric Cancer 1

Interventions

toripalimab 1Pemetrexed 1Paclitaxel 1Erlotinib Hydrochloride 1Docetaxel 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × EGFR Positive Non-small Cell Lung Cancer × Docetaxel × Clear all
NCT06208033 2024-01-17

SMET12 and Toripalimab Combined Chemotherapy in Patients With EGFR Positive Advanced Non-small Cell Lung Cancer (NSCLC)

Fujian Cancer Hospital

Phase EARLY_PHASE1 Unknown
40 enrolled
Thoracic

EGFR Positive Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡